United States: Pharmaceutical market growth
The graph shows the growth of the pharmaceutical market in the U.S. from 2004 to 2010.
Growth of the U.S. pharmaceutical market from 2004 to 2010 (in percent)
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you U.S. pharmaceutical industry
Contribution to global pharma
5
- Premium Statistic World pharmaceutical market distribution by submarket 2014-2023
- Premium Statistic World pharmaceutical sales 2020-2023 by region
- Basic Statistic Market share of the leading global pharmaceutical markets 2023
- Premium Statistic Top global pharmaceutical markets: growth rate 2023
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2023
Overview
6
- Premium Statistic U.S. total medicine spending 2002-2022
- Basic Statistic Leading therapy areas for U.S. drug spending 2020
- Premium Statistic U.S. top prescribed drugs based on sales 2023
- Premium Statistic Top pharma products by prescriptions U.S. 2022
- Premium Statistic Pharmaceutical channel distribution by U.S. spending 2017-2019
- Premium Statistic U.S. biopharmaceutical export volume 2002-2023
Companies
6
- Premium Statistic 2024 list of top U.S. biotech and pharmaceutical companies based on revenue
- Premium Statistic Pharmaceutical corporations by U.S. revenue 2023
- Basic Statistic AbbVie revenue 2010-2023
- Premium Statistic Pfizer revenue 2006-2023
- Premium Statistic Bristol-Myers Squibb's revenue 2006-2023
- Premium Statistic Johnson & Johnson revenue 2005-2023
Research and development
7
- Basic Statistic Research and development expenditure: U.S. pharmaceutical industry 1995-2023
- Premium Statistic U.S. pharma industry R&D spending as a percent of total revenues 1990-2023
- Basic Statistic Pharmaceuticals: cost of drug development in the U.S. since 1975
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2023
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Basic Statistic U.S. sales of new brand medicines 2012-2021
- Basic Statistic R&D expenditure per employee in U.S. sectors 2003-2017
Generics
5
- Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
- Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
- Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2005-2021
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2023
- Premium Statistic Sales share at risk of pharmaceuticals due to patent expiries U.S. 2022
Public view on pharma
6
- Premium Statistic Share of U.S. people who had a favorable view of pharmaceutical companies 2021
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Premium Statistic Share of U.S. adults who approve pharmaceutical companies' drug price handling 2021
- Basic Statistic Share of people who had a favorable view of Pfizer in U.S. 2021
- Basic Statistic Share of people who had a favorable view of Moderna in U.S. 2021
- Premium Statistic Share of people who had a favorable view of J&J in U.S. 2021
Outlook
4
- Premium Statistic World pharmaceutical sales by region forecast 2027
- Premium Statistic Sales at risk of pharmaceuticals due to patent expiries U.S. 2022
- Basic Statistic Leading U.S. pharmaceutical products by revenue 2026
- Basic Statistic U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection
Further related statistics
10
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2019 to 2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Johnson & Johnson's number of employees 2004-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2019 to 2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Johnson & Johnson's number of employees 2004-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
IMS Health. (October 8, 2009). Growth of the U.S. pharmaceutical market from 2004 to 2010 (in percent) [Graph]. In Statista. Retrieved November 17, 2024, from https://www.statista.com/statistics/266105/pharmaceutical-market-growth-in-the-us-since-2004/
IMS Health. "Growth of the U.S. pharmaceutical market from 2004 to 2010 (in percent)." Chart. October 8, 2009. Statista. Accessed November 17, 2024. https://www.statista.com/statistics/266105/pharmaceutical-market-growth-in-the-us-since-2004/
IMS Health. (2009). Growth of the U.S. pharmaceutical market from 2004 to 2010 (in percent). Statista. Statista Inc.. Accessed: November 17, 2024. https://www.statista.com/statistics/266105/pharmaceutical-market-growth-in-the-us-since-2004/
IMS Health. "Growth of The U.S. Pharmaceutical Market from 2004 to 2010 (in Percent)." Statista, Statista Inc., 8 Oct 2009, https://www.statista.com/statistics/266105/pharmaceutical-market-growth-in-the-us-since-2004/
IMS Health, Growth of the U.S. pharmaceutical market from 2004 to 2010 (in percent) Statista, https://www.statista.com/statistics/266105/pharmaceutical-market-growth-in-the-us-since-2004/ (last visited November 17, 2024)
Growth of the U.S. pharmaceutical market from 2004 to 2010 (in percent) [Graph], IMS Health, October 8, 2009. [Online]. Available: https://www.statista.com/statistics/266105/pharmaceutical-market-growth-in-the-us-since-2004/